GRDN vs CVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

GRDN

36.4
AI Score
VS
CVS Wins

CVS

50.3
AI Score

Investment Advisor Scores

GRDN

36score
Recommendation
SELL

CVS

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GRDN CVS Winner
Revenue 688.36M 189.89B CVS
Net Income 35.17M 4.89B CVS
Net Margin 5.1% 2.6% GRDN
Operating Income 38.32M 8.95B CVS
ROE 13.6% 7.8% GRDN
ROA 7.9% 2.2% GRDN
Total Assets 443.58M 220.11B CVS
Cash 89.81M 5.19B CVS
Current Ratio 1.65 0.92 GRDN

Relative Price Performance (Last 90 Days)

GRDN 1M: +13.1% · 3M: +1.3% CVS 1M: -0.1% · 3M: -5.8%

Current Technical Phase

GRDN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 69

RSI (14): 69.5 · Price: $43.64

CVS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 43

RSI (14): 43.1 · Price: $94.66

Fundamentals Snapshot

Metric GRDN CVS
Market Cap
Forward P/E 30.5 11.1
Trailing P/E 41.7 25.2
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.1%
Operating Margin 0.0% 0.0%
EPS 1.05 3.78
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.